Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA

Home

Resources

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 18/10/25 by Hei Wan Wendy Ng

The Power of Less: Evidence-Based De-escalation of Denosumab for Optimal Patient Outcomes and Resource Utilisation

Posters

View resources
Last reviewed: 18/10/25 by Georgia Moseley-Malesi

Equitable Access to Androgen Receptor Inhibitors in Newly Diagnosed Metastatic Prostate Cancer Patients at the Dudley Group NHS Foundation Trust: A Service Evaluation

Posters

View resources
Last reviewed: 18/10/25 by Baguiasri Mandane

Factors influencing medication adherence in patients with multiple myeloma

Posters

View resources
Last reviewed: 18/10/25 by Lilia So

Service Evaluation of Ropeginterferon (Besremi®) Use in Cutaneous T-Cell Lymphoma (CTCL) During the 2024–25 Peginterferon alfa-2a (Pegasys®) Shortage

Posters

View resources
Last reviewed: 18/10/25 by Catherine Loughran

Daratumumab Pre-medication and Observation Times: A Survey of Practice Across the United Kingdom

Posters

View resources
Last reviewed: 18/10/25 by Dharmisha Chauhan

Access to NHS England (NHSE) funded targeted treatments for non-small cell lung cancer (NSCLC)

Posters

View resources
Last reviewed: 18/10/25 by Rena Chauhan

Validation of the NHS England (NHSE) horizon scanning and capacity impact tool (CIT) for forthcoming NICE topics specific for cancer drugs

Posters

View resources
Last reviewed: 18/10/25 by Wing Chung Tong

The Non-medical Prescriber (NMP) Clinical Trials Pharmacist in Research Clinic – A Pilot Study at The Royal Marsden Hospital Foundation Trust

Posters

View resources
Last reviewed: 18/10/25 by Joanne Robinson

Assessment of Deferral Rates per Solid Tumour Type for SACT Prescribed within the West of Scotland

Posters

View resources
Last reviewed: 18/10/25 by Tasneem Ganijee

Real-world predictors of overall survival in glioblastoma patients receiving adjuvant temozolomide: a retrospective cohort analysis

Posters

View resources
Last reviewed: 18/10/25 by Sarah Craig

Exploring the need for a student led pharmacy service to support medicine review in gynaecological cancer clinics in a specialist cancer centre

Posters

View resources
Last reviewed: 18/10/25 by Tracey Keys

Real-World Outcomes of Neoadjuvant FOLFIRINOX in Borderline Resectable and Locally Advanced Pancreatic Cancer: A Single-Centre Retrospective Study

Posters

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 … 7 8 9 … 124 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Latest Conference 2026
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Twitter
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2026 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.